跳至主要内容
临床试验/NCT04233593
NCT04233593已完成1 期

Imaging the Neuroimmune Response to Lipopolysaccharide

Yale University2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2014年3月25日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
27
试验地点
2
主要终点
Baseline TSPO Availability

研究概览

简要总结

In this study, healthy adult volunteers will undergo two positron emission tomography (PET) scans using the radiotracer [11C]PBR28 which binds to the 18kDa translocator protein (TSPO). Approximately 3 hours prior to the second [11C]PBR28 PET scan, lipopolysaccharide (LPS; endotoxin) will be administered to evoke a robust neuroimmune response. Subjects will also undergo behavioral and cognitive testing. Vital signs, subjective response, and peripheral cytokine levels will be assayed periodically throughout the experimental session.

Specific aims: Quantify the magnitude of neuroimmune response after a classical immune stimulus.

Secondary aims: Quantify changes in cognitive function after a classical immune stimulus.

Hypothesis: Individuals will exhibit a robust whole-brain neuroimmune response and impaired cognitive function after LPS.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Medically-healthy male and female subjects able to read/write English

排除标准

  • Subjects cannot meet DSM criteria for substance use disorder
  • Any psychiatric symptoms that could put the subject at risk by participating in the study including but not limited to suicidal or homicidal ideation, or suicide attempt within the last year
  • Pregnancy or breastfeeding;
  • Any current medical illness that could put the subjects at risk during the PET scan, or interfere with the PET or immunologic measures
  • Significant hepatocellular injury (as evidenced by AST or ALT levels greater than 5 times normal or a history of cirrhosis) will be exclusionary in order to reduce the risks associated with alcohol consumption
  • Subjects taking corticosteroids or other immunosuppressant drugs
  • Subjects with disorders affecting the brain, including but not limited to multiple sclerosis, history of stroke, brain tumors, intracranial bleeding, infection, or abscess.

结局指标

主要结局

Baseline TSPO Availability

时间窗: Before LPS administration (baseline)

Time-activity curves will be extracted from brain regions of interest and analyzed using multilinear analysis-1 (t\*=30) incorporating the metabolite-corrected arterial input function to yield \[11C\]PBR28 total volumes of distribution (VT) across brain regions.

次要结局

  • Alcohol Dependence Scale (ADS) - questionnaire(baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kelly Cosgrove

Associate Professor

Yale University

研究点 (2)

Loading locations...

相似试验

Neuroimmune Response to Lipopolysaccharide | 临床试验